NASDAQ: KYTXKyverna Therapeutics Inc Stock Ownership - Who owns Kyverna Therapeutics?
Insider buying vs selling
Have Kyverna Therapeutics Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when KYTX insiders and whales buy or sell their stock.
KYTX Shareholders
What type of owners hold Kyverna Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Vida Ventures LLC | 11.05% | 4,777,060 | $34.25M | Insider |
| Fred E. Cohen | 10.50% | 4,540,558 | $32.56M | Insider |
| Vida Ventures Advisors LLC | 10.46% | 4,523,924 | $32.44M | Institution |
| Gilead Sciences Inc | 9.54% | 4,126,119 | $29.58M | Institution |
| Gilead Sciences Inc | 9.54% | 4,126,119 | $29.58M | Insider |
| Bain Capital Life Sciences Investors LLC | 7.79% | 3,368,370 | $24.15M | Institution |
| Northpond Ventures III GP LLC | 7.53% | 3,255,426 | $23.34M | Insider |
| Bain Capital Life Sciences Investors LLC | 7.32% | 3,163,868 | $22.68M | Insider |
| Price T Rowe Associates Inc | 4.23% | 1,830,501 | $13.12M | Institution |
| Vanguard Group Inc | 3.04% | 1,312,767 | $9.41M | Institution |
KYTX vs Biotech Stocks
Kyverna Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.